Beconase and Lexapro drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Beconase (beclomethasone dipropionate) and Lexapro (escitalopram oxalate). Common drug interactions include asterixis among females and affective disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Beconase and Lexapro. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Beconase?

Beconase has active ingredients of beclomethasone dipropionate. It is often used in asthma. eHealthMe is studying from 1,224 Beconase users. Check the latest studies of Beconase.

What is Lexapro?

Lexapro has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 91,464 Lexapro users. Check the latest studies of Lexapro.



On Jul, 31, 2026

15 people who take Beconase and Lexapro together, and have interactions are studied.

Beconase and Lexapro drug interactions.

What are the common drug interactions of Beconase and Lexapro, by gender? *:

female:

  1. Asterixis (flapping tremor, or liver flap)
  2. Axillary mass
  3. Benign neoplasm of thyroid gland (benign (non-cancerous) tumours of the thyroid gland)
  4. Breast cancer
  5. Breast mass
  6. Breast pain
  7. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  8. Dysarthria (speech disorder)
  9. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  10. Facial bones fracture (bone fracture of face)

male:

  1. Affective disorder (mental disorder)
  2. Anaemia (lack of blood)
  3. Blood immunoglobulin a increased
  4. Bone fistula
  5. Bone pain
  6. Breast pain
  7. Breast swelling
  8. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  9. Cachexia (loss of weight)
  10. Cardiac murmur (an heart sound in valve abnormality)

What are the common drug interactions of Beconase and Lexapro, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Tardive dyskinesia (a disorder that involves involuntary movements)

40-49:

  1. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development)
  2. Intervertebral disc degeneration (spinal disc degeneration)
  3. Joint range of motion decreased (disease of joint movement)
  4. Meningitis aseptic (a condition that causes the membranes covering your brain and spinal cord to become inflamed)
  5. Migraine (headache)
  6. Morton's neuroma (a nerve tumour non cancer that affects one of the nerves that run between the long bones (metatarsals) in the foot)
  7. Oesophageal spasm (contraction of oesophagus)
  8. Oscillopsia (a visual disturbance in which objects in the visual field appear to oscillate)
  9. Pain
  10. Urinary retention (the inability to completely or partially empty the bladder)

50-59:

  1. Pneumonia
  2. Decubitus ulcer (a chronic ulcer of the skin caused by prolonged pressure on it)
  3. Dehydration (dryness resulting from the removal of water)
  4. Septic shock (shock due to blood infection)
  5. Ulcer

60+:

  1. Breast pain
  2. Fall
  3. Breast cancer
  4. Breast mass
  5. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  6. Diverticulum (out pouching of a hollow (or a fluid-filled) structure in the body)
  7. Dysarthria (speech disorder)
  8. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs)
  9. Facial bones fracture (bone fracture of face)
  10. Gastrointestinal disorder (functional problems of gastrointestinal tract)

What are the existing conditions these people have? *

  1. Stable Angina (a constant chest pain): 5 people, 33.33%
  2. Menopausal Symptoms: 5 people, 33.33%
  3. Hypersensitivity: 5 people, 33.33%
  4. High Blood Pressure: 5 people, 33.33%
  5. High Blood Cholesterol: 5 people, 33.33%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 5 people, 33.33%
  7. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 26.67%
  8. Stress And Anxiety: 3 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Beconase and Lexapro?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Beconase and Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Beconase:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lexapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Beconase and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lexapro and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on beclomethasone dipropionate and escitalopram oxalate (the active ingredients of Beconase and Lexapro, respectively), and Beconase and Lexapro (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: